Depression and anxiety as determinants of health-related quality of life in patients with multiple sclerosis - United Arab Emirates

  • Taoufik Alsaadi | talsaadi@live.ca American Center for Psychiatry and Neurology, Abu Dhabi, United Arab Emirates. http://orcid.org/0000-0002-7513-5706
  • Khadija El Hammasi Department of Psychiatry, Sheikh Khalifa Medical City (SKMC), Abu Dhabi, United Arab Emirates.
  • Khadija El Hammasi Department of Psychiatry, Sheikh Khalifa Medical City (SKMC), Abu Dhabi, United Arab Emirates.
  • Tarek M. Shahrour Department of Psychiatry, Sheikh Khalifa Medical City (SKMC), Abu Dhabi, United Arab Emirates.
  • Tarek M. Shahrour Department of Psychiatry, Sheikh Khalifa Medical City (SKMC), Abu Dhabi, United Arab Emirates.
  • Mustafa Shakra American Center for Psychiatry and Neurology, Abu Dhabi, United Arab Emirates.
  • Mustafa Shakra American Center for Psychiatry and Neurology, Abu Dhabi, United Arab Emirates.
  • Lamya Turkawi Department of Neurology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
  • Lamya Turkawi Department of Neurology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
  • Wassim Nasreddine Department of Neurology, American University of Beirut-Medical Center, Lebanon.
  • Wassim Nasreddine Department of Neurology, American University of Beirut-Medical Center, Lebanon.
  • Seada Kassie American Center for Psychiatry and Neurology, Abu Dhabi, United Arab Emirates.
  • Seada Kassie American Center for Psychiatry and Neurology, Abu Dhabi, United Arab Emirates.
  • Mufeed Raoof Department of Psychiatry, Sheikh Khalifa Medical City (SKMC), Abu Dhabi, United Arab Emirates.
  • Mufeed Raoof Department of Psychiatry, Sheikh Khalifa Medical City (SKMC), Abu Dhabi, United Arab Emirates.

Abstract

To study the impact of depression and anxiety on health-related quality of life (HRQOL) in patients with multiple sclerosis (pwMS) in the UAE. All consecutive patients attending the MS clinic over a fourmonth period, October 2014 through February 2015, at Sheikh Khalifa Medical city (SKMC) were asked to complete The World Health Organization quality of life abbreviated scale (WHOQOL-BREF), the Patient Health Questionnaire nine-item (PHQ-9) depression scale, and Generalized Anxiety Disorder seven-item (GAD-7) scale. These last two scales were used to screen for depression and anxiety disorders respectively. The study looked at significant variables associated with HRQOL, using multivariate analysis. Eighty patients were enrolled in the study. Both anxiety and depression had a strong positive correlation with HRQOL in univariate analysis. However, depression was the strongest predictor of HRQOL in the patients using linear multi-regression analysis. Screening and timely treatment of both anxiety and depression in MS patients should be a recommended policy when managing pwMS to improve their optimal care and ensure better quality of life.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2017-12-11
Info
Issue
Section
Articles
Keywords:
Multiple sclerosis, Depression, Anxiety, Health-Related Quality of life, UAE
Statistics
  • Abstract views: 829

  • PDF: 236
  • HTML: 68
How to Cite
Alsaadi, T., El Hammasi, K., El Hammasi, K., Shahrour, T. M., Shahrour, T. M., Shakra, M., Shakra, M., Turkawi, L., Turkawi, L., Nasreddine, W., Nasreddine, W., Kassie, S., Kassie, S., Raoof, M., & Raoof, M. (2017). Depression and anxiety as determinants of health-related quality of life in patients with multiple sclerosis - United Arab Emirates. Neurology International, 9(4). https://doi.org/10.4081/ni.2017.7343